BioCentury
ARTICLE | Product Development

University of Queensland COVID-19 vaccine becomes seventh with CEPI funding to enter the clinic

Plus Altimmune vaccine heads towards the clinic, and Fast Track for Pfizer, BioNTech candidates

July 15, 2020 1:00 AM UTC

As Moderna readies for Phase III testing of its COVID-19 vaccine after reporting more positive data, multiple other vaccines continue to show progress as countermeasures against the virus. A CEPI-funded candidate from the University of Queensland has entered human testing, while a program from Altimmune is expected to enter the clinic next quarter. Meanwhile, a vaccine candidates from Pfizer and BioNTech, which are neck and neck with Moderna’s program, have gained Fast Track status.

The Coalition for Epidemic Preparedness Innovations announced that the first volunteers in a Phase I trial of Queensland’s COVID-19 vaccine were enrolled on Monday. The Australian study will enroll about 120 participants. ...